1-3 of 3
Koichiro Ikuta
Close
Sort by
Journal Articles

Acute Myeloid Leukemia (AML) - Type Chemotherapy for Newly Diagnosed Children with Myelodysplastic Syndrome (MDS): A Japanese Childhood MDS Study Group Trial MDS99.

Yoshitoshi Ohtsuka, MD, Atsushi Manabe, MD, Jun Okamura, MD, Seiji Kojima, MD, Akira Ohara, MD, Masahiro Tuchida, MD, Koichiro Ikuta, MD, Shigeyoshi Hibi, MD, Keisei Kawa, MD, Miharu Yabe, MD, Arata Watanabe, MD, Kazuhiro Ueda, MD, Shinpei Nakazawa, MD, Sumio Miyazaki, MD, Tatsutoshi Nakahata, MD
Journal: Blood
Blood (2004) 104 (11): 4726.
https://doi.org/10.1182/blood.V104.11.4726.4726
Published: 2004
Journal Articles

Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program

Clinical Trials & Observations
Seiji Kojima, Takaharu Matsuyama, Shunichi Kato, Hisato Kigasawa, Ryoji Kobayashi, Atsushi Kikuta, Hisashi Sakamaki, Koichiro Ikuta, Masahiro Tsuchida, Yasutaka Hoshi, Yasuo Morishima, Yoshihisa Kodera
Journal: Blood
Blood (2002) 100 (3): 799–803.
https://doi.org/10.1182/blood.V100.3.799
Published: 2002
Journal Articles

Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children

Clinical Trials & Observations
Seiji Kojima, Akira Ohara, Masahiro Tsuchida, Toru Kudoh, Ryoji Hanada, Yuri Okimoto, Takashi Kaneko, Toshikuni Takano, Koichiro Ikuta, Ichiro Tsukimoto
Journal: Blood
Blood (2002) 100 (3): 786–790.
https://doi.org/10.1182/blood.V100.3.786
Published: 2002